RAPS

NGS Altering the Landscape of Antiviral Drug Resistance Analysis, FDA Officials Say

As next-generation sequencing (NGS) costs gradually decline, the Food and Drug Administration’s (FDA) Division of Antiviral Products (DAVP) anticipates that more companies will make the switch to NGS ...
MarketWatch

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...
Business Wire

Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show

BOSTON--(BUSINESS WIRE)--Velsera and Sentieon are pleased to announce their joint receipt of the Best-of-Show award at Bio-IT World 2024 for their innovative NGS secondary analysis solution, ...

Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies

Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...
RAPS

FDA Officials Review Algorithms Used for NGS Analysis

A group of scientists from the US Food and Drug Administration's (FDA) Division of Bioinformatics and Biostatistics have reviewed the algorithms used to align the data generated by next-generation ...
Labroots

Automating NGS sample preparation to accelerate microbiome research

Automating NGS sample preparation to accelerate microbiome research Microbiome research often involves complex workflows and ...
EurekAlert!

First joint overview of PCR deduplication and error correction revolutionizes NGS data analysis

A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short ...
Business Wire

NuGEN Webinar Features New Sample Prep Method for NGS Analysis of Multiple Changes in 500+ Cancer Gene Targets

SAN CARLOS, Calif.--(BUSINESS WIRE)--NuGEN Technologies is pleased to present a Webinar featuring the company’s newly launched Ovation Cancer Panel 2.0 Target Enrichment System--a sample preparation ...
ascopubs.org

NGS-based molecular panel analysis of metastatic prostate cancer for daily routine: How often do we detect druggable mutations?

Assessment of PARP1 mRNA expression as prognostic of aggressive pathology and adverse outcomes, and as predictor of response to PARP inhibition in castration-sensitive prostate cancer. Association of ...